Partner Article

Northwich-based Dechra Pharmaceuticals PLC remains ‘confident’

Competitor stock shortages in the US have meant strong revenues for Northwich-based Dechra Pharmaceuticals.

The manufacturer of veterinary products has reported that group revenue has increased in this quarter by 14.3% at constant exchange rates and 6% at actual exchange rates.

The European part of the business has seen revenues fall at actual exchange rates by 3.3% however sales were positively impacted by wholesalers buying in advance of Easter.

The company said: “ We remain on track to deliver our strategic milestones and further progress has been made in the period“

This was posted in Bdaily's Members' News section by Sophia Taha .